Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Type III secretion system needle tip protein PcrV is a critical virulence factor found in Pseudomonas aeruginosa, an opportunistic pathogen frequently associated with healthcare-related infections. PcrV is localized at the distal tip of the bacterial Type III secretion system (T3SS) needle, where it acts as a scaffold for the assembly of the translocon pore, composed of the proteins PopB and PopD, within the host cell membrane (UniProt: P72170). This structural assembly is essential for the direct translocation of potent effector toxins, such as ExoS and ExoU, into the host cytoplasm, leading to cellular damage and evasion of the host immune system (Sawa et al., 1999). Due to its external location and high level of conservation across clinical strains, PcrV is a prominent target for passive immunization strategies using monoclonal antibodies. Therapeutic candidates like Gremubamab and KB001-A aim to neutralize PcrV, thereby preventing toxin delivery and attenuating the severity of pneumonia and other invasive P. aeruginosa infections (ClinicalTrials.gov: NCT02696031). This anti-virulence approach provides a potential alternative or adjunct to traditional antibiotics by disarming the pathogen without directly inducing bactericidal selective pressure.
Binding to the PcrV protein at the apex of the T3SS needle prevents the assembly of the translocon pore (PopB/PopD) in the host cell membrane, thereby blocking the injection of cytotoxic effector proteins into host cells (Sawa et al., 1999; DiGiandomenico et al., 2014).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type III secretion system needle tip protein PcrV (PcrV).